Hep Talk

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

Hep C Is Manageable—If You Know the Ins and Outs by Larry Buhl You’ve been diagnosed with Hepatitis C. Now what? First, don’t panic. Doctors agree...

While federal efforts move forward, hepatitis prevention remains unfunded by Larry Buhl During the seemingly interminable debate over health insurance reform, other health legislation was quietly...

In an Effort to Prevent HCV, One Campaign Is Educating Youth on Body Art Risks by Larry Buhl In the U.S., an estimated thirty-six percent of...

What can we do to address the obstacles to HCV treatment? by Larry Buhl Hepatitis C (HCV) is a “silent killer” in more ways than one....

Hep Talk Hepatitis C Antiviral Telaprevir Moves Closer to Approval by Larry Buhl Researchers in a recent Phase III study are encouraged by the results of a...